Clinical Trial

Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 4, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
To explore the consistency between result of PTC drug screening tests and actual clinical outcome for patients with advanced malignancy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-05-08.
Trial Details
NCT Number NCT06413212
Lead Sponsor Liu Huang
Collaborators: Beijing GeneX MedLab Co., Ltd
Conditions Lung Cancer, Breast Cancer, Gastric Cancer, Colorectal Cancer
Enrollment 55 participants
Start Date 2023-08-04
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-06-04